Alpha Cognition Inc

NASDAQ:ACOG USA Biotechnology
Market Cap
$125.23 Million
Market Cap Rank
#19216 Global
#7081 in USA
Share Price
$5.76
Change (1 day)
-0.52%
52-Week Range
$3.75 - $11.24
All Time High
$30.50
About

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatm… Read more

Alpha Cognition Inc - Asset Resilience Ratio

Latest as of March 2024: 40.47%

Alpha Cognition Inc (ACOG) has an Asset Resilience Ratio of 40.47% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$1.41 Million
Cash + Short-term Investments
Total Assets
$3.48 Million
All company assets
Resilience Assessment
Very High
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Alpha Cognition Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Alpha Cognition Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $1.41 Million 40.47%
Total Liquid Assets $1.41 Million 40.47%

Asset Resilience Insights

  • Very High Liquidity: Alpha Cognition Inc maintains exceptional liquid asset reserves at 40.47% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Alpha Cognition Inc Industry Peers by Asset Resilience Ratio

Compare Alpha Cognition Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Alpha Cognition Inc (None–None)

The table below shows the annual Asset Resilience Ratio data for Alpha Cognition Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points